fluorodeoxyglucose f18 has been researched along with Mast-Cell Sarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chaise, C; Copie-Bergman, C; Delfau-Larue, MH; Farcet, JP; Itti, E; Meignan, M; Molinier-Frenkel, V; Petegnief, Y; Talbot, JN; Wirquin, E | 1 |
1 other study(ies) available for fluorodeoxyglucose f18 and Mast-Cell Sarcoma
Article | Year |
---|---|
[F-18]-Fluoro-2-deoxy-D: -glucose positron emission tomography as a tool for early detection of immunotherapy response in a murine B cell lymphoma model.
Topics: Animals; Cancer Vaccines; Cell Line, Tumor; Early Diagnosis; Female; Fluorodeoxyglucose F18; Imaging, Three-Dimensional; Immunocompetence; Immunotherapy, Active; Injections, Intravenous; Liver; Lymph Nodes; Lymphoma, B-Cell; Mast-Cell Sarcoma; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Positron-Emission Tomography; Radiopharmaceuticals; Spleen; Tail | 2007 |